Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes.

Gormsen, Lars C; Søndergaard, Esben; Christensen, Nana L; Brøsen, Kim; Jessen, Niels; Nielsen, Søren

Gormsen, Lars C; Søndergaard, Esben; Christensen, Nana L; Brøsen, Kim; Jessen, Niels; Nielsen, Søren.

Afiliação

Gormsen LC; Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Aarhus, Denmark.
Søndergaard E; Department of Endocrinology, Aarhus University Hospital, Aarhus, Denmark.
Christensen NL; Danish Diabetes Academy, Odense University Hospital, Odense, Denmark.
Brøsen K; Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Aarhus, Denmark.
Jessen N; Department of Pharmacology, Odense University Hospital, Odense, Denmark.
Nielsen S; Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark. Niels.Jessen@biomed.au.dk.

Diabetologia ; 62(7): 1251-1256, 2019 07.

Article em En | MEDLINE | ID: mdl-30976851

Assuntos

Diabetes Mellitus Tipo 2/sangue; Diabetes Mellitus Tipo 2/tratamento farmacológico; Glucose/metabolismo; Hipoglicemiantes/uso terapêutico; Metformina/uso terapêutico; Glicemia/efeitos dos fármacos; Peso Corporal/efeitos dos fármacos; Humanos; Efeito Placebo

Palavras-chave

Clinical trial; Glucose kinetics; Metformin; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Glucose / Hipoglicemiantes / Metformina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Diabetologia Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google